A9641 Novel Angiotensin II Receptor Blocker Azilsartan protects myocardium from ischemic reperfusion injury in experimental rats through Peroxisome Proliferator–Activated Receptor- γ Activation

2018 ◽  
Vol 36 ◽  
pp. e49
Author(s):  
Shanky Garg ◽  
Arya D.S.
Keyword(s):  
Angiotensin Ii ◽  
Reperfusion Injury ◽  
Receptor Blocker ◽  
Angiotensin Ii Receptor Blocker ◽  
Peroxisome Proliferator ◽  
Angiotensin Ii Receptor ◽  
Ischemic Reperfusion Injury ◽  
Peroxisome Proliferator Activated Receptor ◽  
Ischemic Reperfusion

scholarly journals Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms

PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e49642 ◽  
Author(s):  
Yasunori Iida ◽  
Baohui Xu ◽  
Geoffrey M. Schultz ◽  
Vinca Chow ◽  
Julie J. White ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Abdominal Aortic Aneurysms ◽  
Aortic Aneurysms ◽  
Receptor Blocker ◽  
Angiotensin Ii Receptor Blocker ◽  
Angiotensin Ii Receptor ◽  
Abdominal Aortic

911 A Novel Use of Angiotensin II Receptor Blocker (ARB) Losartan to Inhibit AOM Induced Tumorigenesis and Neoangiogenesis in Experimental Colon Cancer

2015 ◽  
Vol 148 (4) ◽  
pp. S-172 ◽  
Author(s):  
Vesta Valuckaite ◽  
Sarah Ruderman ◽  
Anas Almoghrabi ◽  
John Hart ◽  
Almaz Abdyrakov ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Angiotensin Ii ◽  
Receptor Blocker ◽  
Angiotensin Ii Receptor Blocker ◽  
Angiotensin Ii Receptor
Sign in / Sign up

Export Citation Format

Share Document